Ocean Biomedical Shares Outstanding 2022-2024 | OCEA

Ocean Biomedical shares outstanding from 2022 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Ocean Biomedical Shares Outstanding 2022-2024 | OCEA

Ocean Biomedical shares outstanding from 2022 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$146.3B
Gilead Sciences (GILD)$114.5B
Bristol Myers Squibb (BMY)$114.2B
Vertex Pharmaceuticals (VRTX)$108.7B
CSL (CSLLY)$83.4B
Regeneron Pharmaceuticals (REGN)$74.9B
GSK (GSK)$69.3B
Argenex SE (ARGX)$38.7B
Alnylam Pharmaceuticals (ALNY)$31.8B
BioNTech SE (BNTX)$26.8B
Illumina (ILMN)$21.7B
BeiGene (ONC)$20.5B
Biogen (BIIB)$20.5B
Incyte (INCY)$13.9B
Genmab (GMAB)$13.8B
Genmab (GNMSF)$13.7B
Intra-Cellular Therapies (ITCI)$13.4B
Moderna (MRNA)$13.1B
Insmed (INSM)$13B
Bio-Techne Corp (TECH)$12B
BioMarin Pharmaceutical (BMRN)$11.7B
Sarepta Therapeutics (SRPT)$11.3B
Vaxcyte (PCVX)$10.6B
QIAGEN (QGEN)$10.5B
Exelixis (EXEL)$10.3B
Swedish Orphan Biovitrum (BIOVF)$10.1B
Exact Sciences (EXAS)$9.6B
Bio-Rad Laboratories (BIO.B)$9.5B
Repligen (RGEN)$9B
Roivant Sciences (ROIV)$8.1B